NL-OMON43582已完成不适用
Amsterdam Investigator-initiateD ABSORB trial- AIDA CTO Physiology <br> - AIDA CTO Physiology
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •o Subject is enrolled in the Amsterdam Investigator-InitiateD Absorb strategy trial
- •o Subject has a chronic total occlusion
- •o Subject must agree to undergo all clinical investigation plan-required follow-up visits and to undergo follow-up angiography and intracoronary measurements
- •o Subject is able to verbally confirm understanding and he/she or his/her legally authorized representative provides written informed consent prior to any Clinical Investigation related procedure, as approved by the appropriate Ethics Committee.
排除标准
- •o Subject is younger than 18 years of age
- •o Subject has known hypersensitivity or contraindication to Acetylcholine, nitroglycerin, adenosine or contrast that cannot be adequately pre-medicated.
- •o Known renal insufficiency (eg. estimated Glomerular Filtration Rate (eGFR) <60mL/min/1.73m2 or serum creatinine level of >2.5mg/dL or subject on dialysis)
- •o Subject is belonging to a vulnerable population (per investigator*s judgment, e.g., subordinate hospital staff) or subject unable to read or write.
研究者
相似试验
已完成
不适用
Amsterdam Investigator-initiated Absorb trial the bifurcation strategyCoronary Atherosclerosis10011082Coronary Artery DiseaseNL-OMON41341Academisch Medisch Centrum40
已完成
不适用
Amsterdam Investigator-initiateD Absorb strategy all-comers trialcoronary artery diseasecoronary atherosclerosis10011082NL-OMON41656Academisch Medisch Centrum1,790
进行中（未招募）
不适用
First international trial for diagnosia nd treatment of langerhans cell histiocytosis in adults - LCH-A1angerhans cell histiocytosisMedDRA version: 9.1Level: HLTClassification code 10020118Term: HistiocytosesEUCTR2006-002392-40-ITAZ. DI RILIEVO NAZ. E DI ALTA SPECIALIZZAZIONE OSP. CIVICO E BENFRATELLI, G.DI CRISTINA E M.ASCOLI250
招募中
2 期
The Drug Rediscovery Protocol (DRUP trial) A Dutch National Study on behalf of the Center for Personalized Cancer Treatment (CPCT) to Facilitate Patient Access to Commercially Available, Targeted Anti-cancer Drugs to determine the Potential Efficacy in Treatment of Advanced Cancers with a Known Molecular Profiletumors10027655CancerNL-OMON54670ederlands Kanker Instituut1,550
尚未招募
不适用
A scientific trail to evaluate the effect of a 13 week long lifestyle change program, anchored in the science of yoga i.e Swasth Wellness Program (SWP), on the systolic blood pressure, in subjects who are not on any anti-hypertensive treatment.CTRI/2021/03/031779Mr Sundeep Kapalia